CMV - PCR Qualitative, AmnioticFluid

CMV - PCR Qualitative, Amniotic Fluid is an advanced molecular diagnostic test used to detect the presence of Cytomegalovirus (CMV) DNA in amniotic fluid. This highly sensitive Polymerase Chain Reaction (PCR) test plays an important role in prenatal diagnosis by helping identify fetal CMV infection during pregnancy.

Cytomegalovirus is one of the most common congenital infections worldwide. Maternal CMV infection during pregnancy can sometimes be transmitted to the developing fetus, potentially leading to congenital CMV infection. Early detection allows healthcare providers to assess fetal risk, monitor pregnancy more closely, and provide appropriate counseling and management.

Benefits of the Test

• Provides highly sensitive detection of CMV DNA.
• Helps identify congenital CMV infection before birth.
• Supports prenatal diagnosis and fetal assessment.
• Assists in pregnancy management decisions.
• Offers accurate molecular confirmation of infection.
• Useful in pregnancies with suspected fetal CMV exposure.
• Supports genetic and fetal medicine evaluations.
• Provides valuable information for parental counseling.

Why Doctors Recommend This Test

Doctors recommend CMV PCR Qualitative testing on amniotic fluid when maternal CMV infection is suspected or confirmed during pregnancy, abnormal fetal ultrasound findings are present, or there is concern regarding congenital CMV infection. The test helps determine whether CMV has been transmitted to the fetus.

Accurate prenatal diagnosis allows clinicians to provide appropriate monitoring, counseling, and pregnancy management recommendations.

Preparation Before Test

• No fasting is generally required.
• An amniotic fluid sample is collected through amniocentesis by a qualified healthcare specialist.
• The procedure is performed under ultrasound guidance.
• Follow all instructions provided by your obstetrician or fetal medicine specialist.
• Provide relevant pregnancy and infection history.
• Inform your doctor about previous CMV test results if available.

Normal Reporting Time

Most CMV - PCR Qualitative, Amniotic Fluid reports at Focus Diagnostics are available within 2–3 hours for specimen processing and molecular workflow initiation. Final PCR analysis and reporting are generally completed within a few working days depending on laboratory protocols and quality control procedures.

Who Should Take This Test?

This test may be recommended for:

• Pregnant women with suspected CMV infection.
• Patients with confirmed maternal CMV infection.
• Pregnancies with abnormal fetal ultrasound findings.
• Women referred for fetal medicine evaluation.
• Patients at risk of congenital CMV transmission.
• Individuals requiring prenatal infection assessment.
• Pregnancies undergoing detailed fetal monitoring.
• Patients seeking confirmation of fetal CMV infection.

Detailed Information

Cytomegalovirus (CMV) is a common virus belonging to the herpesvirus family. While CMV infection in healthy adults is often mild or asymptomatic, infection during pregnancy may occasionally be transmitted to the fetus through the placenta. Congenital CMV infection is one of the leading infectious causes of hearing loss, developmental delay, and neurological complications in children.

When a pregnant woman acquires a primary CMV infection or experiences viral reactivation, there is a possibility of fetal transmission. Prenatal evaluation becomes particularly important when maternal CMV infection is suspected, serological testing indicates recent infection, or fetal ultrasound findings suggest possible congenital infection.

CMV - PCR Qualitative, Amniotic Fluid testing utilizes advanced molecular amplification technology to detect CMV DNA directly within amniotic fluid. Detection of viral DNA indicates fetal infection and provides important information regarding the presence of congenital CMV.

The test is generally performed after amniocentesis, a specialized prenatal procedure in which a small amount of amniotic fluid surrounding the fetus is collected under ultrasound guidance. PCR analysis offers excellent sensitivity and specificity for detecting CMV genetic material and is considered one of the most reliable methods for prenatal diagnosis of congenital CMV infection.

Results are interpreted together with maternal infection history, CMV serology, fetal ultrasound findings, gestational age, and other prenatal assessments. A positive result confirms fetal infection but does not necessarily predict the severity of disease, making comprehensive fetal evaluation important.

Because prenatal infectious disease testing involves complex clinical considerations, interpretation should be performed by experienced obstetricians, fetal medicine specialists, infectious disease experts, and genetic counselors when appropriate.

At Focus Diagnostics, CMV - PCR Qualitative, Amniotic Fluid testing is performed using advanced molecular diagnostic platforms, highly sensitive PCR technology, and stringent quality assurance standards to provide accurate, reliable, and clinically meaningful prenatal diagnostic results.